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P < 0.01; 36.10%±20.65%, P < 0.01; 28.99%±10.59%, P < 0.01)
and in healthy control group (2.64%±0.42%, P < 0.01;
19.67%±9.09%, P < 0.01; 24.52%±7.52%, P < 0.01). The
frequencies of CD39+treg cells in peripheral blood in
HBV-related ACLF interim group (53.83%±26.62%, P < 0.05)
and late group (52.88% ±23.24%, P < 0.05) were higher
than those in early group (25.44%±8.73%). Eventually,
27 patients completed the dynamic observation in this short-
term follow-up, in improved group, MELD score showed a
gradually decreasing trend, the frequencies of treg cells
showed a gradually rising trend. But in deteriorated group,
MELD score showed a gradually rising trend, the frequencies
of treg cells showed a shortly rising and gradually decreasing
trend. In improved group and deteriorated group, the
frequencies of CD39+treg cells and CTLA-4+treg cells in
peripheral blood were not show signiﬁcant ﬂuctuations.
Conclusion: HBV-related ACLF patients suffered from an
immune imbalance, the expression and dynamic changes
the frequencies of treg cells in peripheral blood can be
used as additional tools in disease progression of clinical
observation and short-term prognosis prediction in those
patients.
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Objective: To investigate the relationship between Vascular
obstruction and progression of hepatic cirrhosis in patients
with chronic HBV.
Study design: 310 patients from 123rd hospital of PLA with
HBV-related cirrhosis received liver biopsy follow-up were
included in this study. HE and immunohistochemical staining
were used to examine the changed in liver pathology. The
scores of hepatic ﬁbrosis grading were determined blindly
by two independent pathologists.
Results: HE and Immunohistochemical staining demon-
strated that patients with high hepatic ﬁbrosis scores
showed intrahepatic vascular obstruction, more ﬁbrous
tissue and a stronger protein expression of VEGF in
endothelial cells compared with patients with low hepatic
ﬁbrosis scores. After intrahepatic injections with Hepatocyte
Growth Factor (HGF), vascular obstruction was markedly
ameliorated and collagen ﬁbers and expression of VEGF in
liver tissue was signiﬁcantly reduced showed by follow-up
liver biopsies compared with the initial liver biopsy.
Conclusions: Our data showed that vascular obstruction
contributes to progression of hepatic cirrhosis in patients
with chronic HBV. This study provided us a new therapeutic
approach to HBV-related liver cirrhosis.
Figure 1. Patients with liver cirrhosis (G4S4, HE × 100).
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Objectives: To investigate the effects of SiRNA mediated
Smad3 silence on proliferation, apoptosis in activated
hepatic stellate cells and the mechanisms involved.
Methods: HSC-T6 cells were divided into three groups: blank
group, negative control group, SiRNA-Smad3 transfection
group. The siRNA-Smad3 was transfected into HSC-T6 cells.
After transfecting with different time, cell proliferation was
measured by CCK-8, cell apoptosis was detected by ﬂow
cytometry, p53 and bcl-2 protein expression was detected
by immunocytochemistry.
Results: (1) After 24 h, 48 h, 72 h of transfection, HSC
proliferation was signiﬁcantly inhibited and apoptosis
increased signiﬁcantly in the transfection group compared
with the blank and negative control group (P < 0.01).
(2) After 48 h of transfection, the expression of p53
protein was increased signiﬁcantly and bcl-2 protein was
signiﬁcantly decreased in the transfection group compared
with the blank and negative control group (P < 0.01).
Conclusion: The Smad3-SiRNA mediated Smad3 silence can
signiﬁcantly inhibit HSC proliferation and induce apoptosis,
Smad3 silence inducing HSC apoptosis may be associated
with up-regulating expression of p53 and down-regulating
expression of bcl-2 on HSC. For the treatment of liver
ﬁbrosis, Smad3 silence may provide a new pathway.
Figure 1. Intrahepatic vascular obstruction in liver tissue (HE ×100).
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Objectives: To investigate the therapeutic effects on liver
failure patients caused by hepatitis B at 48 weeks after
autologous MMSCs transplantation.
Methods: 53 patients (group A) underwent autologous
marrow mesenchymal stem cells (MMSCs) transplantation
and 105 patients with matched age, gender and biochemical
indexes, including alanine aminotransferase (ALT), albumin,
total bilirubin (TBIL), prothrombin time (PT), and Model for
End-Stage Liver Disease (MELD), comprised the group B who
received medical treatments only. 120ml of bone marrow
from patients were obtained and MMSC cell suspension were
separated and slowly transfused into the liver through the
proper hepatic artery. The side effects and complications
were observed. The manifestations of ultrasound and levels
of biochemical indexes were compared through 48 weeks.
